Taligen Therapeutics Headquarters
Looking for information about Taligen Therapeutics Headquarters? The links below have collected all the necessary data.
https://relationshipscience.com/organization/taligen-therapeutics-inc-131177
Taligen's targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts.
https://www.crunchbase.com/organization/taligen-therapeutics
Last Funding Type Series B. Company Type For Profit. Contact Email [email protected]. Phone Number 617-444-8443. Taligen Therapeutics is focused on the discovery and development of novel protein therapeutics that modulate the alternative pathway of the complement system to treat a wide range of inflammatory conditions and diseases.Founded: 2004
https://pitchbook.com/profiles/company/14143-06
Taligen Therapeutics General Information Description. Provider of development stage biotechnology services for the treatment of inflammatory diseases. The company is developing therapies that regulate the complement system to treat inflammatory and immune diseases.
https://www.sbir.gov/node/325829
The Use of Complement Inhibitors as therapeutic agents in AMD. Amount: $175,065.00. DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is the leading cause of blindness for Americans 60 years of age and older. It is estimated that the prevalence of AMD in the ... SBIR Phase I 2006 Department of Health and Human Services ...
https://www.linkedin.com/company/taligen-therapeutics
Taligen Therapeutics 65 followers on LinkedIn. Major Complement therapeutics Company
https://ir.alexion.com/news-releases/news-release-details/alexion-acquires-taligen-therapeutics-and-creates-translational
CHESHIRE, Conn.--(BUSINESS WIRE)-- Alexion Pharmaceuticals, Inc. announced that it has acquired Taligen Therapeutics, Inc., a privately held development-stage biotechnology company based in Cambridge, Mass. The acquisition broadens Alexion's portfolio of product candidates and expands Alexion's capabilities in translational medicine by bringing additional accomplished researchers to the …
https://www.biospace.com/article/releases/taligen-therapeutics-advances-corporate-growth-plan-with-appointment-of-jeffrey-t-walsh-as-chief-business-officer-/
Dec 01, 2008 · Taligen's headquarters and late-stage research and development operations are located in Cambridge, Mass. The company also maintains a drug discovery operation in Denver under Michael Holers, M.D., which closely collaborates with an international complement biology research community.
https://www.biospace.com/article/releases/alexion-pharmaceuticals-inc-acquires-taligen-therapeutics-for-111-million-and-creates-translational-medicine-group-to-accelerate-development-of-exp/
Jan 31, 2011 · Alexion Pharmaceuticals Inc. Acquires Taligen Therapeutics for $111 Million and Creates Translational Medicine Group to Accelerate Development of Expanded Portfolio Published: Jan 31, 2011 CHESHIRE, Conn.--(BUSINESS WIRE)-- Alexion Pharmaceuticals, Inc. announced that it has acquired Taligen Therapeutics, Inc., a privately held development ...
https://www.bizjournals.com/denver/news/2011/02/04/connecticut-company-buys-taligen.html
Feb 04, 2011 · The 16-employee company moved its headquarters to Cambridge, Mass., in 2008 after hiring Abbie Celniker to be CEO. Taligen’s main lab followed in 2009, though Taligen …
Have you found Taligen Therapeutics Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.
Related Pages:
|
Recently Added Pages:
|